Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06094478 · ClinicalTrials.gov registry record · NA
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
A NA study of Stroke, Acute and Hemorrhagic Stroke, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 7
- Study locations
NCT06094478 is a NA study of Stroke, Acute and Hemorrhagic Stroke that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 900 participants, above the 594-participant average among 25 other Stroke, Acute trials with a reported enrollment target (52% higher). The trial reports 7 study locations across 7 states.
The verdict
NCT06094478, a NA study of Stroke, Acute and Hemorrhagic Stroke, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 7
- Study locations
Study Summary
Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.
Conditions Studied
Interventions
- BEHAVIORAL HI-SPEED Protocol
Study Locations (7)
Connecticut
- Yale New Haven Hospital - New Haven
Florida
- Jackson Memorial Hospital - Miami
Georgia
- Emory University Hospital - Atlanta
Illinois
- UChicago Medicine Ingalls Memorial Hospital - Chicago
New York
- New York Presbyterian - Weill Cornell Hospital - New York
Ohio
- University of Cincinnati Medical Center - Cincinnati
Utah
- University of Utah Health - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06094478
The ClinicalTrials.gov registry entry for NCT06094478 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 594-participant average among 25 other Stroke, Acute trials with a reported enrollment target (52% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stroke, Acute appearing as the primary indexed condition, and to 1 intervention - of which HI-SPEED Protocol is the first listed.
NCT06094478 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Connecticut, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT06094478 about?
NCT06094478 is a clinical study titled "Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition". Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments....
What is the current status of trial NCT06094478?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2024-10-17. Estimated completion is 2028-07-31.
What conditions does trial NCT06094478 study?
This clinical trial studies the following conditions: Stroke, Acute, Hemorrhagic Stroke, Ischemic Stroke, Acute.
What interventions are being tested in trial NCT06094478?
The interventions under investigation include: HI-SPEED Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT06094478?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06094478 being conducted?
This trial has 7 study locations across Connecticut, Florida, Georgia, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
RECRUITING · NA
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
RECRUITING · NA
-
ECMO ABI Detection With Hyperfine
RECRUITING · NA
-
EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.